Through artificial intelligence technology, PDHA1 and CDKN2A were successfully identified as cuproptosis-related biomarkers of osteosarcoma, and their potential applications in diagnosis and immunotherapy were validated. This evidence concerns the gene CDKN2A and osteosarcoma.